Abstract
Antenatal glucocorticoids can reduce the frequency and severity of neonatal lung disease by 60%. Variations in maternal and fetal steroid metabolism may affect modify the efficacy of this crucial intervention. We studied the associations between maternal and fetal single nucleotide gene polymorphisms (SNPs) and the frequency of respiratory distress syndrome (RDS) after antenatal exposure to betamethasone.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
